The increasingly popular nicotine pouches pose a lower risk of cancer than cigarettes, U.S. health officials said.

Federal health officials are backing the health benefits of nicotine pouches, ruling that Philip Morris International’s Zyn ...

“The FDA should not be authorizing the sale of any flavored tobacco products ... among the public figures who have embraced Zyn. Philip Morris has stated it does not employ online influencers ...

Morgan Stanley (NYSE:MS) initiated coverage on shares of Philip Morris International Inc. (NYSE:NYSE:PM) shares, bestowing an Overweight rating and establishing a price target of $140. The move ...

The U.S. Food and Drug Administration formally authorized Zyn nicotine pouches for sale after conducting an "extensive ...

Zyn and the retailers who sell the product have run afoul of regulators in recent years. The FDA in April of last year warned ...

The U.S. Food and Drug Administration (FDA) has officially authorized the sale of Zyn nicotine pouches, a significant ...

Philip Morris Intl. expands into cannabis via Avicanna partnership, focusing on medical research and innovation: How this ...

Analyst Lisa Lewandowski from Bank of America Securities maintained a Buy rating on Philip Morris (PM – Research Report) and keeping the price ...

Assenagon Asset Management S.A. lessened its holdings in shares of Philip Morris International Inc. (NYSE:PM – Free Report) ...

We came across a bullish thesis on Philip Morris International Inc. (PM) on Substack by Chit Chat Stocks. In this article, we ...

Morgan Stanley analyst Eric Serotta has maintained their bullish stance on PM stock, giving a Buy rating on January 10.Stay Ahead of the ...